Specifically, the CDC42EP3-206 + TMEM138-211 + IRX3-202-based model achieved maximum predictive efficacy (Rs = 0.94, FDR = 1.8e-09), explaining more than 88% of the ROR variance observed across different tumor types (Figures 5C,D). The gene discussed is TMEM138; the disease is neoplasm.